Company: MYSEW
Filing Date: 2025-02-10
Form Type: 424B5
Source: 0001213900-25-011767
Chunk: 36

Company: Myseum, Inc.
Filing Date: 2025-02-10
Form: 424B5
Chunk 36
---
 of the effectiveness of the registration statement of which this prospectus is a part. We may sell the securities to or through underwriters, dealers or agents or directly to purchasers. We, as well as any agents acting on our behalf, reserve the sole right to accept and to reject in whole or in part any proposed purchase of securities. Each prospectus supplement will set forth the names of any underwriters, dealers or agents involved in the sale of securities described in that prospectus supplement and any applicable fee, commission or discount arrangements with them, details regarding any over-allotment option granted to them, and net proceeds to us. The following is a summary of the securities we may offer with this prospectus.

<div align='center'>-4-</div>

Common Stock

We currently have authorized 180,000,000 shares of common stock, par value $0.0001 per share. As of November 10, 2022, 20,597,419 shares of common stock were issued and outstanding. We may offer shares of our common stock either alone or underlying other registered securities convertible into or exercisable for our common stock. Holders of our common stock are entitled to such dividends as our board of directors (the “Board of Directors” or “Board”) may declare from time to time out of legally available funds, subject to the preferential rights of the holders of any shares of our preferred stock that are outstanding or that we may issue in the future. Currently, we do not pay any dividends on our common stock. Each holder of our common stock is entitled to one vote per share. In this prospectus, we provide a general description of, among other things, the rights and restrictions that apply to holders of our common stock.

Preferred Stock

We currently have authorized 20,000,000 shares of preferred stock, par value $0.0001. As of November 10, 2022, 1 share of our preferred stock have been designated as Series A Preferred Stock, however, there are currently no shares of preferred stock outstanding. The Series A Preferred Stock does not convert into securities of the Company and does not contain any redemption provision. Any authorized and undesignated shares of preferred stock may be issued from time to time in one or more additional series pursuant to a resolution or resolutions providing for such issue duly adopted by our Board of Directors (authority to do so being hereby expressly vested in the Board of Directors). The Board of Directors is further authorized, subject to limitations prescribed by law, to fix by resolution